Showing results (1061-1070 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|May 17, 2021
PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacyChristopher D Zahm, Jena E Moseman, Lauren E Delmastro, et al.
Oncoimmunology|May 17, 2021
Tumor spread or siege immunity: dissemination to distant metastasis or notGabriela Bindea, Bernhard Mlecnik, Jérôme Galon
Oncoimmunology|August 5, 2021
Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacyQingyun Yuan, Qiaoyan Liang, Zujun Sun, et al.
Oncoimmunology|August 5, 2021
DGKζ exerts greater control than DGKα over CD8+ T cell activity and tumor inhibitionJunchen Gu, Cindy Wang, Carolyn Cao, et al.
Oncoimmunology|November 18, 2016
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitopeP Baumgaertner, C Costa Nunes, A Cachot, et al.
Oncoimmunology|November 18, 2016
High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCCYunqing Chen, Ying Xu, Miaoxian Zhao, et al.
Oncoimmunology|November 18, 2016
Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomyDiane Goltz, Heidrun Gevensleben, Jörn Dietrich, et al.
Oncoimmunology|November 18, 2016
CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cellsCaroline W Fugle, Yongliang Zhang, Feng Hong, et al.
Oncoimmunology|November 18, 2016
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemiaEmily M McWilliams, Jennifer M Mele, Carolyn Cheney, et al.
Oncoimmunology|November 18, 2016
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicityJasper J P van Beek, Mark A J Gorris, Annette E Sköld, et al.
Pageof 379